HuagongsheHuagongshe Chemistry Print Report · For research reference only
Piroxicam → Sudoxicam
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Piroxicam | HCID 54676228 | — |
| Reactant | Isoxicam | HCID 54677972 | — |
| Product | Sudoxicam | HCID 54682951 | — |
Reaction Steps
The oxicams may be combined with the special 1,2-diacyl-glycero-3-phosphocholines in a molar ratio of 1:1 to 1:20, preferably in a molar ratio of 1:1 to 1:10. A unit dose for the therapeutic application to humans amounts to 5-300 mg oxicam combined with 10-500 mg 1,2-diacyl-glycerol-3-phosphocholine per day, preferably 10-20 mg for piroxicam and 100-300 mg for isoxicam combined with 50-250 mg 1,1-diacyl-glycero-3-phosphocholine.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US04687766 |
| Source dataset | uspto-grants-1987_08 |
| ORD ID | ord-991606544acc4eb9b91f50e9dac2e1ee |
| Source note | uspto-grants-1987_08 |